You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
富祥藥業(300497.SZ):目前自建有多功能合成生物-生物發酵產線
格隆匯 05-09 07:49

格隆匯5月9日丨富祥藥業(300497.SZ)在投資者互動平台表示,合成生物學是以可再生生物質為原料,以生物體作為生產介質,改造或創造人造生命體系的新興學科。合成生物具有清潔、高效、可再生等特點,在科技和產業創新兩個層面均具備全面顛覆現有格局的潛力,是公司重要發展方向。 目前,公司自建有多功能合成生物-生物發酵產線,同時積累了深厚的生物發酵技術經驗,主要應用在醫藥、食品領域。公司多種酶製劑、羥脯氨酸、微生物蛋白等產品應用了合成生物學技術。 其中,公司的微生物發酵蛋白已實現中試千噸級生產規模。為滿足市場需求,公司擬投資建設年產20萬噸微生物蛋白及其資源綜合利用項目(一期2萬噸),該項目建成投產後可形成年產2萬噸微生物蛋白以及5萬噸氨基酸水溶肥的規模,項目正有序推進中。目前該業務尚未對公司業績產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account